ReviewBiomedicines2022

First-Line Targeted Therapy for Hepatocellular Carcinoma: Role of Atezolizumab/Bevacizumab Combination.

Sri Harsha Tella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.